Literature DB >> 22966382

A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes.

Walid Al Achkar1, Abdulsamad Wafa, Bashar Yousef Ali, Marina Manvelyan, Thomas Liehr.   

Abstract

The so-called Philadelphia (Ph) chromosome is present in more than 90% of chronic myeloid leukemia (CML) patients. Around 5-10% of these patients show complex translocations involving other chromosomes in addition to and/or besides chromosomes 9 and 22. CML cases with fusion transcripts, such as e13a3, in which ABL exon 3 rather than exon 2 has fused to BCR, are extremely rare. Such reported cases with the e13a3 transcript showed the Ph chromosome on karyotype analysis. This study reported a rare Ph chromosome-positive CML case with new complex chromosomal aberrations and an e13a3 BCR-ABL transcript that has yet to be established. A four-chromosome translocation involving chromosomal regions 12p11.2, 19q13.3, 9q34.1 and 22q11.2, besides a trisomy 8 and a derivative chromosome 12, were identified using high resolution multicolor banding. Reverse transcription polymerase chain reaction products showed the presence of BCR-ABL fusion transcript e13a3, and this signifies the major BCR breakpoint. The significance of the observed rearrangements and their possible role in the progression of CML was investigated.

Entities:  

Year:  2010        PMID: 22966382      PMCID: PMC3436393          DOI: 10.3892/ol_00000139

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  17 in total

Review 1.  The molecular biology of chronic myeloid leukemia.

Authors:  M W Deininger; J M Goldman; J V Melo
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

2.  Microdissection based high resolution multicolor banding for all 24 human chromosomes.

Authors:  Thomas Liehr; Anita Heller; Heike Starke; Nikolai Rubtsov; Vladimir Trifonov; Kristin Mrasek; Anja Weise; Alma Kuechler; Uwe Claussen
Journal:  Int J Mol Med       Date:  2002-04       Impact factor: 4.101

3.  CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall.

Authors:  Haifa-Kathria Al-Ali; Sabine Leiblein; Ines Kovacs; Evelin Hennig; Dietger Niederwieser; Michael W N Deininger
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

4.  Molecular definition of high-resolution multicolor banding probes: first within the human DNA sequence anchored FISH banding probe set.

Authors:  Anja Weise; Kristin Mrasek; Ina Fickelscher; Uwe Claussen; Sau Wai Cheung; Wei Wen Cai; Thomas Liehr; Nadezda Kosyakova
Journal:  J Histochem Cytochem       Date:  2008-02-05       Impact factor: 2.479

5.  A chronic myeloid leukemia patient with atypical karyotype and BCR-ABL e13a3 transcript caused by complex chromosome rearrangement.

Authors:  Masayoshi Masuko; Tatsuo Furukawa; Takashi Abe; Reiko Wada; Soichi Maruyama; Toshiki Kitajima; Yasuhiko Shibasaki; Ken Toba; Masahiko Okada; Yoshifusa Aizawa
Journal:  Int J Hematol       Date:  2009-06-30       Impact factor: 2.490

6.  Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology.

Authors:  T H Que; J G Marco; J Ellis; E Matutes; V B Babapulle; S Boyle; D Catovsky
Journal:  Blood       Date:  1993-07-15       Impact factor: 22.113

7.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.

Authors:  E Shtivelman; B Lifshitz; R P Gale; E Canaani
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

Review 8.  Cytogenetics in chronic lymphocytic leukemia.

Authors:  G Juliusson; M Merup
Journal:  Semin Oncol       Date:  1998-02       Impact factor: 4.929

9.  BCR translocation to derivative chromosome 2: a new case of chronic myeloid leukemia with a complex variant translocation and Philadelphia chromosome.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Suher Almedani
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

Review 10.  Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3.

Authors:  Li-Gen Liu; Hideo Tanaka; Kinro Ito; Taiichi Kyo; Takuo Ito; Akiro Kimura
Journal:  Am J Hematol       Date:  2003-12       Impact factor: 10.047

View more
  13 in total

1.  A rare case of three-way complex variant translocation in chronic myeloid leukemia t(6;9;22)(p21;q34;q11): A case report.

Authors:  Muhammad Asif; Abrar Hussain; Abdul Wali; Nazeer Ahmad; Naheed Sajjad; Muhammad Amir; Irfan Ali; Peter Natesan Pushparaj; Mahmood Rasool
Journal:  Biomed Rep       Date:  2017-08-17

2.  Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.

Authors:  Sarah L McCarron; Stephen E Langabeer; Karen Bolger; Karl Haslam; Mireille Crampe; Johanna Kelly; Ruth Morrell
Journal:  Med Oncol       Date:  2015-01-13       Impact factor: 3.064

Review 3.  Role of tyrosine kinase inhibitor in chronic myeloid leukemia patients with SARS-CoV-2 infection: A narrative Review.

Authors:  Muhammad Asif; Muhammad Amir; Abrar Hussain; Niaz M Achakzai; Peter Natesan Pushparaj; Mahmood Rasool
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

4.  Co-existence of isodicentric Ph chromosomes and the three-way Ph chromosome variant t(3;9;22)(p21;q34;q11) in a rare case of chronic myeloid leukemia.

Authors:  Qian Li; Xiao-Ji Lin; Hui Chen; Jian Gong; Zhen Li; Xiang-Nan Chen
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

5.  Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion.

Authors:  Jihye Ha; June Won Cheong; Saeam Shin; Seung Tae Lee; Jong Rak Choi
Journal:  Ann Lab Med       Date:  2016-05       Impact factor: 3.464

6.  A novel dic (17;18) (p13.1;q11.2) with loss of TP53 and BCR/ABL rearrangement in an Imatinib resistant chronic myeloid leukemia.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Faten Moassass; Moneeb Abdullah Kassem Othman
Journal:  Mol Cytogenet       Date:  2012-08-20       Impact factor: 2.009

7.  A new t(9;11;20;22)(q34;p11.2;q11.21;q11) in a Philadelphia-positive chronic myeloid leukemia case.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Thomas Liehr
Journal:  Oncol Lett       Date:  2012-11-21       Impact factor: 2.967

8.  Three-way Philadelphia translocation t(9;10;22)(q34;p11.2;q11.2) as a secondary abnormality in an imatinib mesylate-resistant chronic myeloid leukemia patient.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Adnan Ikhtiar; Thomas Liehr
Journal:  Oncol Lett       Date:  2013-03-05       Impact factor: 2.967

9.  Multiple copies of BCR-ABL fusion gene on two isodicentric Philadelphia chromosomes in an imatinib mesylate-resistant chronic myeloid leukemia patient.

Authors:  Walid Al-Achkar; Abdulsamad Wafa; Faten Moassass; Elisabeth Klein; Thomas Liehr
Journal:  Oncol Lett       Date:  2013-03-05       Impact factor: 2.967

Review 10.  Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities.

Authors:  Elena López Villar; Duojiao Wu; William C Cho; Luis Madero; Xiangdong Wang
Journal:  J Cell Mol Med       Date:  2014-06-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.